GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
TLGYX
Price
$64.91
Change
-$0.08 (-0.12%)
Updated
Jul 16 closing price
Net Assets
170.31M
Interact to see
Advertisement

GFACX vs TLGYX

Header iconGFACX vs TLGYX Comparison
Open Charts GFACX vs TLGYXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
Touchstone Large Company Growth Y
Price$64.91
Change-$0.08 (-0.12%)
VolumeN/A
Net Assets170.31M
GFACX vs TLGYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. TLGYX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and TLGYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. TLGYX (170M). GFACX (0.00) and TLGYX (0.00) have matching dividends . GFACX was incepted earlier than TLGYX: GFACX (24 years) vs TLGYX (9 years). GFACX (1.36) is less costly to investors than TLGYX (1.08). TLGYX is a more actively managed with annual turnover of: 39.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than TLGYX: GFACX (250) vs TLGYX (2500). TLGYX annual gain was more profitable for investors over the last year : 11.90 vs. GFACX (7.11). GFACX return over 5 years is better than : 35.91 vs. TLGYX (31.05).
GFACXTLGYXGFACX / TLGYX
Total Expense Ratio1.360.82166%
Annual Report Gross Expense Ratio1.361.08126%
Fund Existence24 years9 years-
Gain YTD11.29213.34185%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets323B170M190,000%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.1111.9060%
Returns for 3 years52.0172.6272%
Returns for 5 years35.9131.05116%
Returns for 10 years63.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp